Plexxikon Inc. Alternatives & Competitors

12 companies similar to Plexxikon Inc.

Cascadian Therapeutics, Inc.

10 Post-IPO Equity $64.90M

Seattle, United States

Biotechnology Health Care +1

Degron Therapeutics

Aims to become a global leader in the discovery and development of molecular glue degrader...

27 Series A $82.00M

San Diego, United States

Biotechnology Health Care

Flare Therapeutics

Trailblazing the path to drugging transcription factors to discover precision medicines fo...

62 Series B $205.00M

Cambridge, United States

Biopharma Biotechnology +2

Nimbus Therapeutics

We develop breakthrough medicines for patients through precision small molecule design.

103 $637.00M

Boston, United States

Biotechnology Health Care +2

Rival Readout

Competing with Plexxikon Inc.? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

Athersys

Committed to developing therapies to extend and enhance the quality of life.

37 Post-IPO Equity $208.90M

Cleveland, United States

Biopharma Biotechnology +2

Compare

Ambit

Driving breakthroughs in cancer and inflammatory disease treatment through pioneering kina...

197 Venture round $215.73M

Biopharma Biotechnology +1

Denovo Biopharma

29 Grant $1.20B

San Diego, United States

Biopharma Biotechnology +1

Incyclix Bio

Regaining Cell Cycle Control

13 Series B $64.00M

Durham, United States

Biotechnology Health Care +2

Omeros Corporation

Let science lead the way

234 Grant $819.98M

Seattle, United States

Biotechnology Health Care +1

BlackThorn Therapeutics

Pioneering precision medicine for CNS disorders through advanced computational and clinica...

Series B $138.00M

AI Biotechnology +2

vTv Therapeutics

Committed to Improving the Lives of Patients with Diabetes

50 Post-IPO Equity $92.00M

High Point, United States

Biotechnology Health Care +1

Redx Pharma

Biotech company focusing on the discovery and development of novel targeted medicines to t...

39 Post-IPO Equity $78.90M

United Kingdom

Biotechnology Health Care +1

About Plexxikon Inc.

Plexxikon Inc. is a biotechnology company founded in 2000 and headquartered in the United States. As a member of the Daiichi Sankyo Group, Plexxikon specializes in the discovery and development of innovative, small molecule pharmaceuticals through its proprietary discovery platform.

Business keywords

Pharmaceuticals, Drug Discovery, Small Molecule, Precision Medicine, Clinical Trials, Oncology, Metabolic Disease, CNS, Inflammation, Cardiovascular, Diabetes Treatment, Kinase Inhibitors, Therapeutic Indications, Commercialization

Frequently Asked Questions

Companies similar to Plexxikon Inc. include Cascadian Therapeutics, Inc., Degron Therapeutics, Flare Therapeutics, Nimbus Therapeutics, Athersys. They work in Biotechnology and Health Care and share Plexxikon Inc.'s focus on oncology, drug discovery and clinical trials.

Bounce Watch lists 12 companies that share Plexxikon Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Plexxikon Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Plexxikon Inc. Profile Cascadian Therapeutics, Inc. Alternatives Degron Therapeutics Alternatives Flare Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Plexxikon Inc. on 12 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.